{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T22:23:51Z","timestamp":1775687031025,"version":"3.50.1"},"reference-count":66,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015539","name":"Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015539","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.vaccine.2024.04.031","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T19:46:29Z","timestamp":1714765589000},"page":"3404-3409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Determinants of uptake of influenza, zoster and pneumococcal vaccines in patients with cardiovascular diseases"],"prefix":"10.1016","volume":"42","author":[{"given":"Elizabeth","family":"Benedict Kpozehouen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C Raina","family":"Macintyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy C.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.04.031_b0005","unstructured":"Australian Bureau of Statistics. Causes of Death, Australia, 2019 2020 [cited 2020 4 January]. Available from: https:\/\/www.abs.gov.au\/statistics\/health\/causes-death\/causes-death-australia\/2019."},{"key":"10.1016\/j.vaccine.2024.04.031_b0010","unstructured":"WHO. The top 10 causes of death 2019 2020 [cited 2021 6 January ]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/the-top-10-causes-of-death."},{"key":"10.1016\/j.vaccine.2024.04.031_b0015","unstructured":"AIHW. Cardiovascular disease 2020 [cited 2020 30 December]. Available from: https:\/\/www.aihw.gov.au\/reports\/heart-stroke-vascular-diseases\/cardiovascular-health-compendium\/contents\/how-many-australians-have-cardiovascular-disease."},{"issue":"14","key":"10.1016\/j.vaccine.2024.04.031_b0020","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.jacc.2018.02.013","article-title":"Respiratory syncytial virus and associations with Cardiovascular disease in adults","volume":"71","author":"Ivey","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"10.1016\/j.vaccine.2024.04.031_b0025","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1086\/656587","article-title":"Prevention of acute myocardial infarction and stroke among elderly persons by dual pneumococcal and influenza vaccination: a prospective cohort study","volume":"51","author":"Hung","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2024.04.031_b0030","first-page":"245","article-title":"Influenza and pneumococcal immunization in cardiovascular prevention","volume":"74","author":"Liprandi","year":"2014","journal-title":"Medicina (Argentina)"},{"issue":"14","key":"10.1016\/j.vaccine.2024.04.031_b0035","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1093\/eurheartj\/ehr004","article-title":"Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome","volume":"32","author":"Phrommintikul","year":"2011","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.vaccine.2024.04.031_b0040","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4161\/hv.26858","article-title":"Effectiveness of the influenza vaccine at preventing hospitalization due to acute exacerbation of cardiopulmonary disease in Korea from 2011 to 2012","volume":"10","author":"Seo","year":"2014","journal-title":"Hum Vaccines Immunother"},{"issue":"21","key":"10.1016\/j.vaccine.2024.04.031_b0045","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1136\/heartjnl-2015-307691","article-title":"Acute myocardial infarction and influenza: a meta-analysis of case-control studies","volume":"101","author":"Barnes","year":"2015","journal-title":"Heart"},{"issue":"22","key":"10.1016\/j.vaccine.2024.04.031_b0050","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2024.04.031_b0055","first-page":"98","article-title":"Beneficial effects of vaccination on Cardiovascular events: Myocardial Infarction, stroke","volume":"141","author":"Fountoulaki","year":"2018","journal-title":"Heart Failure Cardiology"},{"issue":"5","key":"10.1016\/j.vaccine.2024.04.031_b0060","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.tcm.2020.06.003","article-title":"The impact of influenza vaccination in patients with cardiovascular disease: an overview of systematic reviews","volume":"31","author":"Rodrigues","year":"2021","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.vaccine.2024.04.031_b0065","article-title":"Elderly vaccination\u00a1\u00aaThe glass is half full","volume":"05No.12:6","author":"MacIntyre","year":"2013","journal-title":"Health"},{"key":"10.1016\/j.vaccine.2024.04.031_b0070","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.mib.2015.11.003","article-title":"Infection in an aging population","volume":"29","author":"Kline","year":"2016","journal-title":"Curr Opin Microbiol"},{"issue":"3","key":"10.1016\/j.vaccine.2024.04.031_b0075","first-page":"194","article-title":"Can vaccinations improve Heart failure outcomes?: Contemporary data and future directions. JACC","volume":"5","author":"Bhatt","year":"2017","journal-title":"Heart Failure"},{"issue":"7","key":"10.1016\/j.vaccine.2024.04.031_b0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219172","article-title":"Influenza vaccination and secondary prevention of cardiovascular disease among taiwanese elders\u2014A propensity score-matched follow-up study","volume":"14","author":"Wu","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.04.031_b0085","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ypmed.2017.09.009","article-title":"Associations between complementary medicine utilization and influenza\/pneumococcal vaccination: results of a national cross-sectional survey of 9151 australian women","volume":"105","author":"Wardle","year":"2017","journal-title":"Prev Med"},{"key":"10.1016\/j.vaccine.2024.04.031_b0090","unstructured":"Australian government department of health and aged care. Australian Immunisation Handbook - Zoster (herpes zoster) 2022 [cited 2023 June 13]. Available from: https:\/\/immunisationhandbook.health.gov.au\/contents\/vaccine-preventable-diseases\/zoster-herpes-zoster."},{"key":"10.1016\/j.vaccine.2024.04.031_b0095","unstructured":"Australian Technical Advisory Group on Immunisatin (ATAGI). Statement on the technical use of zoster vaccines in adults in Australia 2022 [cited 2023 October 20]. Available from: https:\/\/www.health.gov.au\/sites\/default\/files\/documents\/2022\/05\/statement-on-the-clinical-use-of-zoster-vaccine-in-older-adults-in-australia-statement-on-the-clinical-use-of-zoster-vaccine-in-older-adults-in-australia.pdf."},{"key":"10.1016\/j.vaccine.2024.04.031_b0100","unstructured":"Australian government department of health and aged care. Australian Immunisation Handbook - Zoster (herpes zoster) 2022 [cited 2023 13 June]. Available from: https:\/\/immunisationhandbook.health.gov.au\/contents\/vaccine-preventable-diseases\/zoster-herpes-zoster."},{"issue":"34","key":"10.1016\/j.vaccine.2024.04.031_b0105","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1016\/j.vaccine.2015.04.038","article-title":"Hesitancy tSWGoV. Diagnosing the determinants of vaccine hesitancy in specific subgroups: the guide to tailoring immunization programmes (TIP)","volume":"33","author":"Robb","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.031_b0110","unstructured":"National Centre for Immunisation Research and Surveillance. National influenza vaccination coverage - all people 2023 [cited 2023 October 6]. Available from: https:\/\/ncirs.org.au\/influenza-vaccination-coverage-data\/national-influenza-vaccination-coverage-all-people."},{"key":"10.1016\/j.vaccine.2024.04.031_b0115","unstructured":"National Centre for Immunisation Research and Surveillance. Annual Immunisation Coverage Report 2021 Summary 2020 [cited 2023 October 6]. Available from: https:\/\/ncirs.org.au\/sites\/default\/files\/2022-12\/Coverage%20report%202021%20SUMMARY%20FINAL.pdf."},{"key":"10.1016\/j.vaccine.2024.04.031_b0120","doi-asserted-by":"crossref","unstructured":"Lu P-j, O'Halloran A, Ding H, Srivastav A, Williams WW. Uptake of Influenza Vaccination and Missed Opportunities Among Adults with High-Risk Conditions, United States, 2013. The American Journal of Medicine. 2016;129(6):636.e1-.e11.","DOI":"10.1016\/j.amjmed.2015.10.031"},{"issue":"4","key":"10.1016\/j.vaccine.2024.04.031_b0125","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s10096-019-03485-3","article-title":"Adult vaccination for pneumococcal disease: a comparison of the national guidelines in Europe","volume":"38","author":"Bonnave","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2024.04.031_b0130","first-page":"326","article-title":"Influenza vaccination and risk of hospitalization in patients with heart failure: a self-controlled case series study","volume":"38","author":"Mohseni","year":"2016","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.vaccine.2024.04.031_b0135","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.vaccine.2017.12.019","article-title":"How close are countries of the WHO european region to achieving the goal of vaccinating 75% of key risk groups against influenza? results from national surveys on seasonal influenza vaccination programmes, 2008\/2009 to 2014\/2015","volume":"36","author":"Jorgensen","year":"2018","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2024.04.031_b0140","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1016\/j.vaccine.2011.01.116","article-title":"Patterns and determinants of influenza and pneumococcal immunisation among adults with chronic disease living in Queensland","volume":"29","author":"Dower","year":"2011","journal-title":"Australia Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2024.04.031_b0145","first-page":"582","article-title":"nfluenza and pneumococcal vaccination in patients with Cardiovascular disease: pilot project","volume":"84","author":"Villarreal","year":"2016","journal-title":"Rev Argent Cardiol"},{"key":"10.1016\/j.vaccine.2024.04.031_b0150","unstructured":"National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases. Immunisation coverage data and reports 2022 [cited 2023 August 1]. Available from: https:\/\/ncirs.org.au\/health-professionals\/immunisation-coverage-data-and-reports."},{"key":"10.1016\/j.vaccine.2024.04.031_b0155","doi-asserted-by":"crossref","unstructured":"Truong J, Bakshi S, Wasim A, Ahmad M, Majid U. What factors promote vaccine hesitancy or acceptance during pandemics? A systematic review and thematic analysis. Health promotion international. 2022;37(1):daab105.","DOI":"10.1093\/heapro\/daab105"},{"issue":"9","key":"10.1016\/j.vaccine.2024.04.031_b0160","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.3390\/vaccines10091518","article-title":"Causes of vaccine hesitancy in adults for the influenza and Covid-19 vaccines: a systematic literature review","volume":"10","author":"Kumar","year":"2022","journal-title":"Vaccines"},{"issue":"6","key":"10.1016\/j.vaccine.2024.04.031_b0165","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.vaccine.2019.12.004","article-title":"Factors associated with perceptions of influenza vaccine safety and effectiveness among adults, United States, 2017\u20132018","volume":"38","author":"Lutz","year":"2020","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2024.04.031_b0170","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1017\/S0950268817000814","article-title":"Beliefs and attitudes towards the influenza vaccine in high-risk individuals","volume":"145","author":"Santos","year":"2017","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2024.04.031_b0175","doi-asserted-by":"crossref","unstructured":"Scheres J, Kuszewski K. The Ten Threats to Global Health in 2018 and 2019. A welcome and informative communication of WHO to everybody. Zeszyty Naukowe Ochrony Zdrowia Zdrowie Publiczne i Zarzadzanie. 2019;17(1):2-8.","DOI":"10.4467\/20842627OZ.19.001.11297"},{"key":"10.1016\/j.vaccine.2024.04.031_b0180","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jaut.2015.03.003","article-title":"Impact of cytokine in type 1 narcolepsy: role of pandemic H1N1 vaccination?","volume":"60","author":"Lecendreux","year":"2015","journal-title":"J Autoimmun"},{"issue":"3","key":"10.1016\/j.vaccine.2024.04.031_b0185","first-page":"E268","article-title":"Review of strategies to enhance the uptake of seasonal influenza vaccination by australian healthcare workers","volume":"36","author":"Stuart","year":"2012","journal-title":"Commun Dis Intell Q Rep"},{"issue":"4","key":"10.1016\/j.vaccine.2024.04.031_b0190","doi-asserted-by":"crossref","first-page":"307","DOI":"10.47102\/annals-acadmedsg.V39N4p307","article-title":"Survey of healthcare workers' attitudes, beliefs and willingness to receive the 2009 pandemic influenza a (H1N1) vaccine and the impact of educational campaigns","volume":"39","author":"Thoon","year":"2010","journal-title":"Ann Acad Med Singap"},{"issue":"37","key":"10.1016\/j.vaccine.2024.04.031_b0195","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1016\/j.vaccine.2020.07.004","article-title":"Acceptability and perception of the herpes zoster vaccine in the 65 and over population: a french observational study","volume":"38","author":"Del Signore","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.031_b0200","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ijid.2020.07.038","article-title":"The protective effect of pneumococcal vaccination on cardiovascular disease in adults: a systematic review and meta-analysis","volume":"99","author":"Marra","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.04.031_b0205","doi-asserted-by":"crossref","unstructured":"Klaric JS, Beltran TA, McClenathan BM. An Association Between Herpes Zoster Vaccination and Stroke Reduction Among Elderly Individuals. Military Med 2019;184(Supplement_1):126-32.","DOI":"10.1093\/milmed\/usy343"},{"key":"10.1016\/j.vaccine.2024.04.031_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2019.107983","article-title":"Diabetes as a risk factor for herpes zoster in adults: a synthetic literature review","volume":"159","author":"Saadatian-Elahi","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"10.1016\/j.vaccine.2024.04.031_b0215","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.pec.2019.12.008","article-title":"Cardiovascular-targeted patient education and uptake of influenza vaccination in elderly patients","volume":"103","author":"Schattner","year":"2020","journal-title":"Patient Educ Couns"},{"issue":"2","key":"10.1016\/j.vaccine.2024.04.031_b0220","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.lpm.2012.06.025","article-title":"Which vaccination and cardiovascular prevention in elderly?","volume":"42","author":"Krypciak","year":"2013","journal-title":"Presse Medicale"},{"issue":"43","key":"10.1016\/j.vaccine.2024.04.031_b0225","doi-asserted-by":"crossref","first-page":"19014","DOI":"10.2807\/ese.13.43.19014-en","article-title":"Trends in influenza vaccination coverage rates in the United Kingdom over six seasons from 2001\u20132 to 2006\u20137","volume":"13","author":"Blank","year":"2008","journal-title":"Eurosurveillance"},{"issue":"1","key":"10.1016\/j.vaccine.2024.04.031_b0230","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1467-842X.2005.tb00745.x","article-title":"Prevalence and determinants of influenza vaccination in australians aged 40 years and over\u2013a national survey","volume":"29","author":"Horby","year":"2005","journal-title":"Aust N Z J Public Health"},{"issue":"15","key":"10.1016\/j.vaccine.2024.04.031_b0235","doi-asserted-by":"crossref","first-page":"e019671","DOI":"10.1161\/JAHA.120.019671","article-title":"Determinants of influenza vaccine uptake in patients with Cardiovascular disease and strategies for improvement","volume":"10","author":"Bhugra","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.vaccine.2024.04.031_b0240","unstructured":"Australian Government Department of Health. Australian Immunisation Handbook 2020 [cited 2021 30 January]. Available from: https:\/\/immunisationhandbook.health.gov.au\/."},{"issue":"4","key":"10.1016\/j.vaccine.2024.04.031_b0245","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1071\/AH19196","article-title":"Does policy change to allow pharmacist provision of influenza vaccination increase population uptake? A systematic review","volume":"44","author":"Spinks","year":"2020","journal-title":"Australian Health Review"},{"issue":"1","key":"10.1016\/j.vaccine.2024.04.031_b0250","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1186\/s12889-019-8044-y","article-title":"Pharmacy-based interventions to increase vaccine uptake: report of a multidisciplinary stakeholders meeting","volume":"19","author":"Ecarnot","year":"2019","journal-title":"BMC Public Health"},{"issue":"4","key":"10.1016\/j.vaccine.2024.04.031_b0255","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/1753-6405.13094","article-title":"Pharmacy, workplace or primary care? where australian adults get their influenza vaccines","volume":"45","author":"Trent","year":"2021","journal-title":"Aust N Z J Public Health"},{"issue":"4","key":"10.1016\/j.vaccine.2024.04.031_b0260","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.sapharm.2019.06.015","article-title":"Successful implementation and provision of enhanced and extended pharmacy services","volume":"16","author":"Hattingh","year":"2020","journal-title":"Res Soc Adm Pharm"},{"issue":"5","key":"10.1016\/j.vaccine.2024.04.031_b0265","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/1715163518783000","article-title":"Evidence for pharmacist vaccination","volume":"151","author":"Isenor","year":"2018","journal-title":"Canadian Pharmacists Journal \/ Revue des Pharmaciens du Canada"},{"issue":"2","key":"10.1016\/j.vaccine.2024.04.031_b0270","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s11096-016-0255-z","article-title":"Who uses pharmacy for flu vaccinations? population profiling through a UK pharmacy chain","volume":"38","author":"Anderson","year":"2016","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.vaccine.2024.04.031_b0275","unstructured":"Australian Bureau of Statistics. Migration, Australiam Statistics on Australia's international migration, internal migration (interstate and intrastate), and the population by country of birth 2020 [Available from: https:\/\/www.abs.gov.au\/statistics\/people\/population\/migration-australia\/latest-release."},{"issue":"44","key":"10.1016\/j.vaccine.2024.04.031_b0280","doi-asserted-by":"crossref","first-page":"6724","DOI":"10.1016\/j.vaccine.2019.09.025","article-title":"Barriers and facilitators of immunisation in refugees and migrants in Australia: an east-african case study","volume":"37","author":"Abdi","year":"2019","journal-title":"Vaccine"},{"issue":"46","key":"10.1016\/j.vaccine.2024.04.031_b0285","doi-asserted-by":"crossref","first-page":"7217","DOI":"10.1016\/j.vaccine.2020.09.054","article-title":"Interventions to reduce the burden of vaccine-preventable diseases among migrants and refugees worldwide: a scoping review of published literature, 2006\u20132018","volume":"38","author":"Charania","year":"2020","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2024.04.031_b0290","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/tay131","article-title":"Reducing infectious disease inequities among migrants","volume":"26","author":"Heywood","year":"2019","journal-title":"J Travel Med"},{"issue":"2","key":"10.1016\/j.vaccine.2024.04.031_b0295","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/1753-6405.12602","article-title":"Improving access to immunisation for migrants and refugees: recommendations from a stakeholder workshop","volume":"41","author":"Kpozehouen","year":"2017","journal-title":"Aust N Z J Public Health"},{"issue":"20","key":"10.1016\/j.vaccine.2024.04.031_b0300","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1016\/j.vaccine.2019.04.001","article-title":"Vaccine-preventable diseases and immunisation coverage among migrants and non-migrants worldwide: a scoping review of published literature, 2006 to 2016","volume":"37","author":"Charania","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.031_b0305","unstructured":"Australian Government Department of Health. Vaccination for special risk groups: Advice and recommendations when vaccinating special risk groups 2018 [updated 5 December 2018. Available from: https:\/\/immunisationhandbook.health.gov.au\/vaccination-for-special-risk-groups."},{"issue":"10","key":"10.1016\/j.vaccine.2024.04.031_b0310","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.3390\/ijerph15102065","article-title":"Interventions to improve vaccination uptake and cost effectiveness of vaccination strategies in newly arrived migrants in the EU\/EEA: a systematic review","volume":"15","author":"Hui","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.vaccine.2024.04.031_b0315","unstructured":". Australian Government Department of Health. Australia Immunisation Handbook 2020 [cited 2021 15 January]. Available from: https:\/\/immunisationhandbook.health.gov.au\/."},{"issue":"2","key":"10.1016\/j.vaccine.2024.04.031_b0320","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taz007","article-title":"Infectious diseases at different stages of migration: an expert review","volume":"26","author":"Greenaway","year":"2019","journal-title":"J Travel Med"},{"issue":"2","key":"10.1016\/j.vaccine.2024.04.031_b0325","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jiph.2019.07.022","article-title":"Influenza vaccine uptake among older adults in Brazil: socioeconomic equality and the role of preventive policies and public services","volume":"13","author":"Sato","year":"2020","journal-title":"J Infect Public Health"},{"issue":"3","key":"10.1016\/j.vaccine.2024.04.031_b0330","doi-asserted-by":"crossref","first-page":"e59272","DOI":"10.1371\/journal.pone.0059272","article-title":"Influenza vaccination uptake among the working age population of Japan: results from a national cross-sectional survey","volume":"8","author":"Wada","year":"2013","journal-title":"PLoS One"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24004456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24004456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T20:56:16Z","timestamp":1716843376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24004456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":66,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0264410X24004456"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.04.031","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determinants of uptake of influenza, zoster and pneumococcal vaccines in patients with cardiovascular diseases","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.04.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}